Evidence map›Paper›PMID 33781348›Full record

GuidelineSystematic reviews2021

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt, Isabelle Boutron, Tammy C Hoffmann, Cynthia D Mulrow, Larissa Shamseer, Jennifer M Tetzlaff, Elie A Akl, Sue E Brennan and 16 more

Abstract readGuideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Systematic reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6,685 papers, 67 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6,685citing papers in PubMed, 67 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6,685 citing papers in PubMed, 67 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Mastitis as a risk factor for breast cancer: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Pooled it
  10. Pooled it
  11. Use of Wearable Sensors in Angelman Syndrome: A Systematic Review.Journal of intellectual disability research : JIDR · 2026
    Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Enhancing Weight Loss Programs: A Meta-Analysis of Financial Incentives and Behavior Change Techniques.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Pooled it

6,625 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Matthew J PageSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. matthew.page@monash.edu.ORCID 0000-0002-4242-7526
Joanne E McKenzieSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Patrick M BossuytDepartment of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, Netherlands.
Isabelle BoutronUniversité de Paris, Centre of Epidemiology and Statistics (CRESS), Inserm, F 75004, Paris, France.
Tammy C HoffmannInstitute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia.
Cynthia D MulrowAnnals of Internal Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Larissa ShamseerKnowledge Translation Program, Li Ka Shing Knowledge Institute, Toronto, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Jennifer M TetzlaffEvidence Partners, Ottawa, Canada.
Elie A AklClinical Research Institute, American University of Beirut, Beirut, Lebanon; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Sue E BrennanSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Roger ChouDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, USA.
Julie GlanvilleYork Health Economics Consortium (YHEC Ltd), University of York, York, UK.
Jeremy M GrimshawClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada; Department of Medicine, University of Ottawa, Ottawa, Canada.
Asbjørn HróbjartssonCentre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, JB Winsløwsvej 9b, 3rd Floor, 5000 Odense, Denmark; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
Manoj M LaluDepartment of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada; Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Canada; Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Tianjing LiDepartment of Ophthalmology, School of Medicine, University of Colorado Denver, Denver, Colorado, United States; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Elizabeth W LoderDivision of Headache, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Head of Research, The BMJ, London, UK.
Evan Mayo-WilsonDepartment of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, Indiana, USA.
Steve McDonaldSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Luke A McGuinnessPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Lesley A StewartCentre for Reviews and Dissemination, University of York, York, UK.
James ThomasEPPI-Centre, UCL Social Research Institute, University College London, London, UK.
Andrea C TriccoLi Ka Shing Knowledge Institute of St. Michael's Hospital, Unity Health Toronto, Toronto, Canada; Epidemiology Division of the Dalla Lana School of Public Health and the Institute of Health Management, Policy, and Evaluation, University of Toronto, Toronto, Canada; Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.
Vivian A WelchMethods Centre, Bruyère Research Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Penny WhitingPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
David MoherCentre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

Funding

Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US ProjectUG1EY020522 · NEI · UNIVERSITY OF COLORADO DENVER · PI Tianjing Li · 2017 to 2026
$10.1M
NEI NIH HHS UG1 EY020522
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PublishingSystematic Reviews as TopicHumansQuality Control

Identifiers

PMID33781348
PMCPMC8008539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.